Cover Image

Prevalence of Bone Density Reduction and Its Related Factors in Hemophilia Patients in South Khorasan Province in 2018

Alireza Ehsanbakhsh, Ghodsiyeh Azarkar, Masood Ziaee, Ali Taghavieh
Background: The present study aimed to determine the prevalence of bone density reduction and its associated factors in hemophilia patients in South Khorasan Province in 2018. Materials and Methods: This case-control study was conducted on all patients with hemophilia type A with medical records in Hemophilia center in South Khorasan province. A number of 57 eligible subjects who met the criteria were selected based on census method. Thereafter, 60 non-hemophilic individuals who were similar to hemophilic patients in terms of age and body mass index were selected by convenience sampling method. DXA device was used to measure bone mineral density (BMD) in two locations of femoral neck and lumbar vertebrae. Data were analyzed in SPSS software (version 19), using Chi-square, Fisher’s exact test, and independent t-test. A P-value less than 0.05 was considered statistically significant. Results: The prevalence rate of bone density reduction in spine bone in hemophilia patients was measured at 31.6% and 13.3% in non-hemophilia subjects (P=0.02); moreover, this rate in hip bone was reported as 7% and 5%, respectively (P=0.65). Relative frequency of bone density reduction in the spine and hip bone was not significantly different among hemophilia patients based on age, severity of hemophilia, vitamin D, hepatitis and smoking (P>0.05). However, a significant difference was detected in terms of body mass index (P<0.05). Conclusion: Based on the obtained results, the prevalence of bone density reduction in hemophilic patients was significantly higher, as compared to that of non-hemophilia patients. This necessitates the implementation of drastic preventive measures, prompt diagnosis, timely treatment, and appropriate therapeutic measures. [GMJ.2020;9:e1711]
Bone Mineral Density; Hemophilia; Bone Mineral Density; Associated Factors

Behrman R, Kligman R, Janson H. Nelson text book of pediatrics. 18th ed. Philadelphia: Saunders 2008; 1657-60.

Owaidah T, Al Momen A, Alzahrani H, Almusa A, Alkasim F, Tarawah A, et al. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia, Results from the Saudi national hemophilia screening program. Medicine (Baltimore). 2017; 96(2):e5456.

https://doi.org/10.1097/MD.0000000000005456

PMid:28079788 PMCid:PMC5266150

Falk B, Portal S, Tiktinsky R, Zigel L, Weinstein Y, Constantini N, et al. Bone properties and muscle strength of young haemophilia patients. Haemophilia. 2005; 11(4):380-6.

https://doi.org/10.1111/j.1365-2516.2005.01116.x

PMid:16011592

Dorgalaleh A, Dadashizadeh G, Bamedi T. Hemophilia in Iran. Hematology. 2016; 21(5):300-10.

https://doi.org/10.1080/10245332.2015.1125080

PMid:26914731

Roushan N, Meysamie A, Managhchi M, Esmaili J, Dormohammadi T. Bone Mineral Density in Hemophilia Patients. Indian J Hematol Blood Transfus. 2014; 30(4):351-5.

https://doi.org/10.1007/s12288-013-0318-4

PMid:25435741 PMCid:PMC4243395

WHO. Prevention and Management of Osteoporosis: Report ofa WHO Scientific Group. Geneva: World Health Organization; 2003:1-120.

Raisz LG, Shoukri KG. Pathogenesis of osteoporosis. In: Mundy GR, Martin TJ. Pharmacology of bone. New York: Springer-Verlag; 1993. P. 299-323.

https://doi.org/10.1007/978-3-642-77991-6_9

Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am. 2003; 32:115-34.

https://doi.org/10.1016/S0889-8529(02)00062-2

Origa R, Fiumana E, Gamberini MR, Armari S, Mottes M, Sangalli A, et al. Osteoporosis in betathalassemia: Clinical and genetic aspects. Ann New York Acad Scie. 2005; 1054:451-6.

https://doi.org/10.1196/annals.1345.051

PMid:16339696

Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, et al. Official positions of the International Society for Clinical Densitometry. J Clin Endocrinol Metab. 2004; 89(8):3651-5.

https://doi.org/10.1210/jc.2004-0124

PMid:15292281

Gurevitch O, Slavin S. The hematological etiology of osteoporosis. Med Hypotheses. 2006; 67(4):729-35.

https://doi.org/10.1016/j.mehy.2006.03.051

PMid:16797864

Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W, et al. Treatment of osteoporosis in men. Bone. 2013; 53(1):134-44.

https://doi.org/10.1016/j.bone.2012.11.018

PMid:23201268 PMCid:PMC3662207

Brennan SL, Henry MJ, Wluka AE, Nicholson GC, Kotowicz MA, Pasco JA. Socioeconomic status and bone mineral density in a pop¬ulation-based sample of men. Bone. 2010; 46(4):993-9.

https://doi.org/10.1016/j.bone.2009.12.029

PMid:20053386

Guthrie JR, Ebeling PR, Dennerstein L, Wark JD. Riskfactors for osteoporosis: Prevalence, change and associationwith bone density. Medscape Womens Health. 2000; 5(5):2-7.

Anagnostis P, Vakalopoulou S, Slavakis A, Charizopoulou M, Kazantzidou E, Chrysopoulou T, et al. Reduced bone mineral density in patients with haemophilia A and B in Northern Greece. Thromb Haemost. 2012; 107(3):545-51.

https://doi.org/10.1160/TH11-08-05563

PMid:22318743

Nair AP, Jijina F, Ghosh K, Madkaikar M, Shrikhande M, Nema M. Osteoporosis in young haemophiliacs from western India. Am J Hematol. 2007;82(6):453-7.

https://doi.org/10.1002/ajh.20877

PMid:17278114

Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Gompakis N, Athanassiou-Metaxa M. Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA). J Pediatr Hematol Oncol. 2010; 32(7):e259-63.

https://doi.org/10.1097/MPH.0b013e3181e8cd40

PMid:20736845

Hoch AZ, Pajewski NM, Moraski L, Carrera GF, Wilson CR, Hoffmann RG, et al. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med. 2009;19(5):421-8.

https://doi.org/10.1097/JSM.0b013e3181b8c136

PMid:19741317 PMCid:PMC2848387

Gerstner G, Damiano ML, Tom A, Worman C, Schultz W, Recht M, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Hemophilia. 2009; 15(2):559-65.

https://doi.org/10.1111/j.1365-2516.2008.01963.x

PMid:19187193

Kiper Unal HD, Comert Ozkan M, Atilla FD, Demirci Z, Soyer N, Yildirim Simsir I, et al. Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study. Am J Blood Res. 2017;7(5):59-66.

Naderi A, Nikvarz M, Arasteh M, Shokoohi M. Osteoporosis/ osteopenia and hemophilic arthropathy in severe hemophilic patients. Arch Iran Med. 2012; 15(2):82-4.

Bazrafshan HR, Qorbani M, ShadpourRashti H, Aghaei M, Safari R. Prevalence of osteoporosis and its association with demographic characterirstics -Gorgan, Iran. Hormozgan Med J. 2011; 15(1):56-62.

Ehsanbakhsh AR, Akhbari H, Bahri Iraee M, Sailanian Toosi F, Khorashadizadeh N, Rezvani MR,et al. The Prevalence of Undetected Vertebral Fracture in Patients with Back Pain by Dual-Energy X-ray Absorptiometry (DXA) of the Lateral Thoracic and Lumbar Spine. Asian Spine J. 2011; 5(3):139-45.

https://doi.org/10.4184/asj.2011.5.3.139

PMid:21892385 PMCid:PMC3159061

Omar Mostafa N, Adolf Habib S, El Adham EK. Evaluation of Bone Mineral Density in Egyptian Hemophilia A Children. Austral J Basic Appl Sci. 2011; 5(12):2812-16.

Kempton CL, Antun A, Antoniucci DM. Carpenter W, Ribeiro M, Stein S, et al. Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia. 2014; 20(1):12240.

https://doi.org/10.1111/hae.12240

PMid:23902277 PMCid:PMC3849333

Abd EL Naeem RS, EL Sebaie EI Hefnawy H, Abd EL Naser Abd EL Aziz O, Mohamed Ezz EL Din EI Mikkawy D, Abdel Gawad Tantawy A, et al. Assessment of Bone Mineral Density and Functional status in Children with Hemophilic. Arthropathy. 2016; 5(1):035-41.

Eshghi P, Moradveisi B. Frequency of Decreased Bone Mineral Density and Its Risk Factors during Childhood among Iranian Hemophilia Patients. IJBC. 2012; 1:13-7.

Lorio A, Fabbriciani G, Marcucci M, Brozzetti M, Filipponi P. Bone mineral density in haemophilia patients.A meta-analysis. Thromb Haemost. 2010; 103(3):596-603.

https://doi.org/10.1160/TH09-09-0629

PMid:20076854

Sossa Melo CL, Wandurraga EA, Pena AM, Jimenez SI, Salazar LA, Ochoa ME,et al. Low bone mineral density and associated factors in patients with haemophilia in Colombia. Haemophilia. 2018; 24(4):e222-9.

https://doi.org/10.1111/hae.13516

PMid:29902356

Darby SC, Keeling DM, Spooner RJ, Wan Kan S, Giangrande PL, Collins PW, et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost. 2004; 2(7):1047-54.

https://doi.org/10.1046/j.1538-7836.2004.00710.x

PMid:15219185

Barnes C, Wong P, Egan B, Speller T, Cameron F, Jones G, et al. Reduced bone density among children with severe hemophilia. Pediatrics. 2004; 114(2):e177-81.

https://doi.org/10.1542/peds.114.2.e177

PMid:15286254

Refbacks

  • There are currently no refbacks.